首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >A new era for small molecule screening: from new targets such as JAK2 V617F to complex cellular screens
【2h】

A new era for small molecule screening: from new targets such as JAK2 V617F to complex cellular screens

机译:小分子筛查的新时代:从新靶标(例如JAK2 V617F)到复杂的细胞筛查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Traditionally reserved to research and development in pharmaceutical companies, screening of small molecule libraries is rapidly becoming an approach undertaken by academic laboratories. Novel cellular assays, sensitive systems to probe function, emerging new molecular targets are just some of the reasons explaining this shift. Targets of small molecules identified in cellular screens begin to be amenable to identification by elegant genetic approaches, such as probing toxicity of candidate small molecules on libraries of genetically modified yeast strains. Several new targets, such as JAK2 V617F, an activated JAK2 (Janus Kinase 2) mutant genetically associated with the majority of human myeloproliferative neoplasms, are being actively pursued. In this Review Series, we will learn how libraries of small molecules are harnessed to identify novel molecules, that alone or in combination, have the ability to alter cell fate, cell signalling, gene expression or response to extracellular cues.
机译:传统上保留给制药公司进行研究和开发,小分子文库的筛选正迅速成为学术实验室采取的一种方法。新颖的细胞分析,灵敏的探测功能系统,新兴的分子靶点只是解释这种转变的部分原因。在细胞筛选中鉴定的小分子靶标开始适合通过优雅的遗传方法鉴定,例如在基因修饰的酵母菌株文库中探查候选小分子的毒性。人们正在积极寻求一些新的靶标,例如与大多数人类骨髓增生性肿瘤遗传相关的活化的JAK2(Janus激酶2)突变体JAK2 V617F。在本综述系列中,我们将学习如何利用小分子文库来鉴定新颖分子,这些新颖分子单独或组合具有改变细胞命运,细胞信号转导,基因表达或对细胞外信号的反应的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号